Financial Performance - FutureFuel Corp. reported a net loss of $10.4 million, or $0.24 per diluted share, for the second quarter of 2025, compared to a net income of $9.6 million, or $0.22 per diluted share, in the same period of 2024 [10][28] - Revenues for the second quarter were $35.7 million, a decrease of 51% from $72.4 million year-over-year [10][12] - Adjusted EBITDA was ($9.8) million, down from $6.9 million in the prior year [10][31] Segment Performance - The BioDiesel segment faced significant challenges due to high input prices and uncertainty regarding support under the IRA 45Z, leading to a decision to temporarily idle the biodiesel plant in June 2025 [3][4] - The Chemicals segment experienced a slower start due to weaker market demand but has expanded its project pipeline with new opportunities expected to commercialize by the end of Q4 2025 and Q1 2026 [5][6] Capital Expenditures and Investments - Capital expenditures increased to $9.5 million in 2025 from $5.3 million in the same period in 2024, primarily due to the construction of a new custom chemical plant [16] - The company continues to invest in plant reliability and efficiency during the downturn in the BioDiesel market [7][8] Cash and Dividends - Cash and cash equivalents totaled $95.2 million as of June 30, 2025, down from $109.5 million at the end of 2024 [17][26] - FutureFuel paid a regular quarterly cash dividend of $0.06 per share in the second quarter of 2025, with additional dividends planned for September and December [9] Market Conditions and Future Outlook - The company anticipates that feedstock prices will normalize, allowing for the resumption of biodiesel production later in 2025 or early 2026 [4] - FutureFuel's management remains focused on maintaining cost control and leveraging its diversified chemical activities to support revenue during the BioDiesel downturn [8][18]
FutureFuel Releases Second Quarter 2025 Results